The addition of pelvic lymph node treatment to prostate bed salvage radiotherapy - Authors' reply

Affiliations

¹ Department of Radiation Oncology, University of Miami Miller School of Medicine and Sylvester Comprehensive Cancer Center, Miami, FL 33136, USA. Electronic address: apollack@med.miami.edu.
² Department of Public Health Sciences, University of Chicago, Chicago, IL, USA; NRG Oncology, Philadelphia, PA, USA.
³ Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
⁴ Department of Medicine, Tulane University, New Orleans, LA, USA.
⁵ Cedars Sinai Medical Center, Los Angeles, CA, USA.

Comment

Alan Pollack et al. Lancet. 2022.

. 2022 Sep 17;400(10356):885-886.

doi: 10.1016/S0140-6736(22)01434-9.

¹ Department of Radiation Oncology, University of Miami Miller School of Medicine and Sylvester Comprehensive Cancer Center, Miami, FL 33136, USA. Electronic address: apollack@med.miami.edu.
² Department of Public Health Sciences, University of Chicago, Chicago, IL, USA; NRG Oncology, Philadelphia, PA, USA.
³ Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
⁴ Department of Medicine, Tulane University, New Orleans, LA, USA.
⁵ Cedars Sinai Medical Center, Los Angeles, CA, USA.

No abstract available

Comment on

The addition of pelvic lymph node treatment to prostate bed salvage radiotherapy.
Kahvecioglu A, Yilmaz MT, Hurmuz P. Kahvecioglu A, et al. Lancet. 2022 Sep 17;400(10356):884-885. doi: 10.1016/S0140-6736(22)01488-X. Lancet. 2022. PMID: 36116476 No abstract available.
The addition of pelvic lymph node treatment to prostate bed salvage radiotherapy.
Turco F, Gillessen S, Bosetti DG, Zilli T, Vogl UM. Turco F, et al. Lancet. 2022 Sep 17;400(10356):885. doi: 10.1016/S0140-6736(22)01482-9. Lancet. 2022. PMID: 36116478 No abstract available.